Matching patients to clinical trials with large language models
Patient recruitment is challenging for clinical trials. We introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models. TrialGPT comprises three modules: it first performs large-scale filtering to retrieve candidate trials (TrialGPT-Retrieval); then predicts criterion-level patient eligibility (TrialGPT-Matching); and finally generates trial-level scores (TrialGPT-Ranking). We evaluate TrialGPT on three cohorts of 183 synthetic patients with over 75,000 trial annotations. TrialGPT-Retrieval can recall over 90% of relevant trials using less than 6% of the initial collection. Manual evaluations on 1015 patient-criterion pairs show that TrialGPT-Matching achieves an accuracy of 87.3% with faithful explanations, close to the expert performance. The TrialGPT-Ranking scores are highly correlated with human judgments and outperform the best-competing models by 43.8% in ranking and excluding trials. Furthermore, our user study reveals that TrialGPT can reduce the screening time by 42.6% in patient recruitment. Overall, these results have demonstrated promising opportunities for patient-to-trial matching with TrialGPT.
Authors
- Changlin Gong (ORCID: https://orcid.org/0000-0001-9932-0538)
- Dara Bracken‐Clarke (ORCID: https://orcid.org/0000-0002-1105-1079)
- Fangyuan Chen (ORCID: https://orcid.org/0000-0002-9891-4753)
- Charalampos S. Floudas (ORCID: https://orcid.org/0000-0002-0020-237X)
- Zifeng Wang (ORCID: https://orcid.org/0000-0002-3026-9970)
- Elisabetta Xue (ORCID: https://orcid.org/0000-0002-1963-9555)
- Zhiyong Lu (ORCID: https://orcid.org/0000-0001-9998-916X)
- Jimeng Sun (ORCID: https://orcid.org/0000-0003-1512-6426)
- Qiao Jin (ORCID: https://orcid.org/0000-0002-1268-7239)
- Yifan Yang (ORCID: https://orcid.org/0000-0003-4414-9176)
Institutions
- National Institutes of Health (US)
- Albert Einstein College of Medicine (US)
- University of Illinois Urbana-Champaign (US)
- University of Pittsburgh (US)
- National Center for Biotechnology Information (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- University of Maryland, College Park (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-11-18
- DOI
- https://doi.org/10.1038/s41467-024-53081-z
- Citations
- 170
- Primary Topic
- Topic Modeling
- Type
- article
- Field-Weighted Citation Impact
- 58.71
Funders
- National Institutes of Health
- U.S. National Library of Medicine